Background/Aims: The association between ACYP2 (Acylphosphatase 2) polymorphisms and immunoglobulin A nephropathy (IgAN) risk in the Chinese Han population remains unclear. We aimed to evaluate the association between ACYP2 polymorphisms and IgAN risk by performing a case-control study. Methods: Eleven ACYP2 single nucleotide polymorphisms (SNPs) from 416 IgAN patients and 495 healthy controls were genotyped using the Sequenom MassARRAY platform. Odds ratio (OR) and 95% confidence interval (CI) were calculated to evaluate the association of ACYP2 polymorphisms with IgAN risk. Results: We observed that rs843720 was significantly associated with an increased risk of IgAN (allele G: OR = 1.23, 95% CI: 1.01-1.49, p = 0.036; dominant model: OR = 1.55, 95% CI: 1.01-2.37, p = 0.044; log-additive model: OR = 1.43, 95% CI: 1.04-1.95, p = 0.026) before Bonferroni correction. The SNP rs12615793 was also significantly associated with an increased IgAN risk in the recessive model (OR = 3.33, 95% CI: 1.05-10.51, p = 0.042) before Bonferroni correction. Conclusion: These findings suggested that polymorphisms (rs843720 and rs12615793) of ACYP2 may be pivotal in the development of IgAN. However, more functional and association studies with larger sample sizes should be performed to further validate our results in the future.
Introduction
The immunoglobulin A nephropathy (IgAN) is the most common form of primary glomerulonephritis in the world and is characterized by the excessive deposition of IgAN in the mesangial area of glomeruli leading to mesangial proliferation and chronic glomerular inflammation [1, 2] . Previous studies have shown that about 30% of IgAN patients will progress to end-stage renal disease within 20-25 years of disease onset [3] . Poor prognostic factors for progression of renal damage in patients with IgAN include gender, older age, hypertension, severe proteinuria, renal lesions, and advanced histological involvement [4] . Furthermore, a family history of chronic nephritis, susceptibility to the common cold, preference for salty foods, frequent consumption of raw eggs, and a high intake of carbohydrates are significantly associated with increased IgAN risk [5] . To date, the exact pathogenesis of IgAN remains unclear. However, increasing lines of evidences have suggested the involvement of genetic factors in the pathogenesis of IgAN and variation in clinical manifestation. Evidence derived from experimental models of spontaneous IgAN and studies of the genetics, familial clustering, ethnic and geographic differences in prevalence support the influence of genetic factors in the development and progression of IgAN [6] [7] [8] [9] . Previous studies have identified multiple susceptibility polymorphisms for the risk of IgAN [10] [11] [12] [13] . Therefore, identifying genes associated with susceptibility to IgAN is particularly important and might provide a genetic target for therapeutic intervention in IgAN.
ACYP2 (Acylphosphatase 2) encodes a small cytosolic enzyme acylphosphatase (11 kDa) that can hydrolyze the phosphoenzyme intermediate of different membrane pumps, particularly the Ca 2+ /Mg 2+ -ATPase from sarcoplasmic reticulum of skeletal muscle [14] . These enzymes can adjust the stability of the inner environment through calcium ion transport [15] . Polak-Jonkisz et al. [16] found that the Ca 2+ /Mg 2+ -ATPase activity is reduced, and Ca 2+ homeostasis is disturbed in children with chronic kidney disease. Moreover, it also exacerbates renal function deterioration. In addition, a genome-wide association study found that rs11125529 in ACYP2 is significantly associated with telomere length [17] . Accumulating evidence prompts the view that telomere length is an indicator for organismal aging. To our best knowledge, aging is one of the contributing risk factors for kidney diseases. It was reported that telomere shortening is associated with human IgAN [18, 19] . Some association studies have demonstrated that polymorphisms in ACYP2 are associated with the susceptibility to many diseases, such as high-altitude pulmonary edema [20] , breast cancer [21] , lung cancer [22] , gastric cancer [23] , and ischemic stroke [24] .
However, to our knowledge, there are no reported studies of the association between ACYP2 polymorphisms and the risk of IgAN among the Chinese Han population. We hypothesized that polymorphisms in ACYP2 are associated with the risk of IgAN. To test this hypothesis, therefore, we conducted a case-control association study to evaluate the association between the ACYP2 polymorphisms and IgAN risk in the Chinese Han population.
Materials and Methods

Subjects
In this study, 416 patients diagnosed with IgAN by renal biopsy were enrolled from the First Affiliated Hospital of Xi'an Jiaotong University. 495 unrelated healthy controls were randomly selected from those who went to the aforementioned hospital for medical examination during the same period. Renal biopsy pathological diagnostic criteria established by Zou (2011) were used as diagnostic criteria for IgAN. All the selected individuals are ethnic Han Chinese with no genetic relationship and their ancestors had lived in the region for at least three generations. Patients with Henoch-Schönlein purpura, systemic lupus erythematosus, allergic purpura, chronic liver diseases, ankylosing spondylitis renal damage, and other secondary IgAN were excluded through detailed clinical and laboratory examinations. The patients were recruited without age, sex, or disease stage restriction.
DNA Extraction
A 5-mL sample of peripheral venous blood was collected in EDTA vacutainer tube from each participant on an empty stomach in the morning and then placed at -80 ° C for cryopreservation. Genomic DNA was isolated from whole blood using the GoldMag DNA Purifcation Kit (GoldMag Co. Ltd., Xi'an, China) according to the manufacturer's protocol and preserved at -20 ° C [25] . The extracted DNA was assessed for concentration and purity utilizing an ultraviolet spectrophotometer (NanoDrop 2000; Thermo Fisher Scientific, Waltham, MA, USA) [26] . The purity was monitored by the (OD 260 -OD 320 )/(OD 280 -OD 320 ) ratio. The DNA concentration was diluted to 10 ng/μL for polymerase chain reaction amplification.
Single Nucleotide Polymorphism Selection and Genotyping
Eleven single nucleotide polymorphisms (SNPs; rs6713088, rs12621038, rs1682111, rs843752, rs843645, rs11125529, rs12615793, rs843711, rs11896604, rs17045754, and rs843720) in the ACYP2 gene with minor allele frequency > 0.05 in the Chinese Han Beijing population from the HapMap database and previously reported [20] [21] [22] [23] [24] were selected for analysis in our study. The primers of SNPs were designed by the Sequenom MassARRAY Assay Design 3.0 Software (Sequenom, San Diego, CA, USA). The sequences of primers corresponding to each SNP are shown in Table 1 . Genotyping of the 11 SNPs were conducted using the Sequenom MassARRAY platform (Sequenom) according to the standard protocol recommended by the manufacturer [27] . Sequenom Typer 4.0 software was used for data management and analysis.
Statistical Analysis
Whether the genotype frequency distribution of control was consistent with HardyWeinberg equilibrium was estimated using the χ 2 test. The difference in the distribution of allele frequencies between cases and controls were compared by the χ 2 test, and the odds ratio (OR) and 95% confidence interval (CI) indicated relative risk. Genetic model and haplotype analyses were applied using unconditional multivariate logistic regression analysis 
Results
Characteristics of Subjects
The characteristics of cases and controls enrolled in this study are shown Table 2 . This study recruited 911 subjects, including 416 IgAN patients (145 females and 271 males) and 495 healthy controls (315 females and 180 males). There was a significant difference between the case and control groups with respect to gender distribution (p < 0.05). The average age of IgAN patients was 33.35 ± 12.13 years compared with 54.48 ± 9.44 years in controls, which also showed statistically significant difference (p < 0.05). In order to eliminate those residual confounding effects, the variables of age and gender were adjusted in later multivariate unconditional logistic regression analysis.
Allele Distributions of ACYP2 Polymorphisms
The allele distribution of the selected SNPs in cases and controls is shown in Table 3 . The genotypic distribution of all SNPs in the control group conformed to Hardy-Weinberg equilibrium (p > 0.05). We found that the frequency of rs843720 G allele in cases (38.5%) was higher than in the controls (33.7%), and the G allele of rs843720 was significantly associated with an increased the risk of IgAN (OR = 1.23, 95% CI: 1.01-1.49, p = 0.036). However, there was no significant difference in other allele distributions of ACYP2 polymorphisms between IgAN patients and controls.
Genetic Model Analyses
Genetic model analysis indicated that the AA genotype of rs12615793 was significantly associated with an increased risk of IgAN, compared to the GG and AG genotypes (adjusted Table 4) . After Bonferroni correction, the significance of multiplex detection at the p < 0.004 (0.05/11) level was not retained for rs12615793 and rs843720. In addition, no association was found between other polymorphisms of ACYP2 and IgAN risk in the genetic models. 
Haplotype Analysis Seven SNPs in the ACYP2, including rs1682111, rs843752, rs843645, rs11125529, rs12615793, rs843711, and rs11896604 showed significant LD, as shown in Figure 1 . Five haplotypes were revealed after the combination of seven SNPs in ACYP2. When the putative risk genotypes were combined and used as the reference ATTCGCC haplotype, no significant difference in the haplotype frequency distributions between the IgAN patient and control groups was found (p > 0.05). The results are presented in Table 5 .
SNP Genotypes and Clinical Indicator Levels
We compared the mean levels of clinical indicators between three genotypes of rs843720 (Table 6 ). There was significant difference in the mean level of HB between the GT genotype and TT genotype groups with IgAN (p < 0.05). However, no significant difference in the mean levels of other clinical indicators was found between the GT genotype and TT genotype groups, and the GG genotype and TT genotype groups with IgAN (p > 0.05).
Discussion
To date, there have been no reports on the correlation between the polymorphisms of ACYP2 and IgAN risk. In this case-control study, we aimed to investigate the association between polymorphisms of ACYP2 and the risk of IgAN in the Chinese Han population. The results revealed that the rs843720 G allele significantly increased the risk of IgAN, and rs843720 was associated with increased risk in both the dominant model and log-additive model before Bonferroni correction. In addition, we found that rs12615793 was also significantly associated with increased risk of IgAN in the recessive model. However, no significant difference in the distribution of allele and genotype was observed in other nine SNPs of ACYP2 between the IgAN patients and the controls (p > 0.05).
ACYP2 (2p16.2) encodes a cytosolic enzyme acylphosphatase, which can adjust the stability of the inner environment of Ca 2+ [15] , and plays a role in pyruvate metabolism [28] , cell differentiation [29] , senescence [30] , and apoptosis [31] . Recently, a genome-wide metaanalysis had successfully identified that rs11125529 was associated with shorter telomere length in the European population [17] . In humans, telomere shortening takes place in many tissues with age, and is accelerated in chronic diseases and cancer [32] . Some reports have identified that telomere shortening is associated with the progression of IgAN [18, 19] . However, we did not observe any significant association between rs11125529 and the risk of IgAN. One possibility is that rs11125529 may not correlate with shorter telomere length in the Chinese Han population. There is another possibility that rs11125529 is a consequence of the IgAN rather than occurring prior to disease development. It will be necessary to reveal the detailed causes in further studies.
The results of this study demonstrated that rs843720 and rs12615793 significantly increased the risk of IgAN. Therefore, the association provided evidence that rs843720 and rs12615793 might be influential factors for telomere length and increase the risk of IgAN by affecting telomere length. However, no difference in the mean levels of clinical indicators (except for HB) was found between the wild-type and mutant types of the rs843720 groups. The finding suggested that rs843720 may increase the risk of IgAN through other mechanisms. Moreover, the Ca 2+ /Mg 2+ -ATPase activity was found to be reduced, and Ca 2+ homeostasis is disturbed in children with chronic kidney disease [16] . It may be that rs843720 and rs12615793 affect the Ca 2+ /Mg 2+ -ATPase activity and calcium homeostasis and thus affect the development of kidney disease [16] . Therefore, further studies are required to investigate the detailed mechanisms of IgAN development.
The rs843720 has been reported to be significantly correlated with increased lung cancer risk in the recessive model [22] . Moreover, previous research showed that the AA genotype of rs12615793 was associated with a decreased risk of high-altitude pulmonary edema, compared to the GG and AG genotypes [33] , but allele A of rs12615793 was found to be associated with an increased risk of ischemic stroke in the Chinese Han population [24] . This suggests that polymorphisms may affect diseases differently.
This study has some limitations. First, the study sample is relatively small, which limits the ability to determine the association between ACYP2 polymorphisms and the risk of IgAN. Second, a more closely matched population may reveal differences that were not found in this study, as the characteristics of the healthy control group were significantly different from those of the IgAN patients group. Third, many other risk factors (e.g., smoking, drinking) and clinical and pathological characteristics were not included. Finally, the biological function analyses of ACYP2 polymorphisms were not performed.
Conclusions
In conclusion, this study indicated that rs843720 and rs12615793 are associated with increased risk of IgAN in the Chinese Han population, which suggested the two polymorphisms might play a role in the development of IgAN in the Chinese Han population. However, further analysis must be performed with a larger sample size to enhance the power of the study and expand the knowledge of the functions of ACYP2 polymorphisms in the development of IgAN.
